Regen BioPharma Inc
OTC:RGBP

Watchlist Manager
Regen BioPharma Inc Logo
Regen BioPharma Inc
OTC:RGBP
Watchlist
Price: 0.0576 USD
Market Cap: 1.8m USD

Intrinsic Value

The intrinsic value of one RGBP stock under the Base Case scenario is 0.0203 USD. Compared to the current market price of 0.0576 USD, Regen BioPharma Inc is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RGBP Intrinsic Value
0.0203 USD
Overvaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Regen BioPharma Inc

What is Valuation History?
Compare RGBP to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RGBP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Regen BioPharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Regen BioPharma Inc

Current Assets 151.8k
Cash & Short-Term Investments 1.8k
Receivables 149.7k
Other Current Assets 300
Non-Current Assets 17.7k
Long-Term Investments 17.7k
Efficiency

Free Cash Flow Analysis
Regen BioPharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Regen BioPharma Inc

Revenue
236.6k USD
Operating Expenses
-604.7k USD
Operating Income
-368.1k USD
Other Expenses
-349.6k USD
Net Income
-717.7k USD
Fundamental Scores

RGBP Profitability Score
Profitability Due Diligence

Regen BioPharma Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive ROE
Declining Operating Margin
Low 3Y Average Gross Margin
25/100
Profitability
Score

Regen BioPharma Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

RGBP Solvency Score
Solvency Due Diligence

Regen BioPharma Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
26/100
Solvency
Score

Regen BioPharma Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RGBP Price Targets Summary
Regen BioPharma Inc

There are no price targets for RGBP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Regen BioPharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RGBP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one RGBP stock?

The intrinsic value of one RGBP stock under the Base Case scenario is 0.0203 USD.

Is RGBP stock undervalued or overvalued?

Compared to the current market price of 0.0576 USD, Regen BioPharma Inc is Overvalued by 65%.

Back to Top